Chapter 725 Wcdcgc E, Dalseg R, Caug<strong>an</strong>t DA, Poolm<strong>an</strong> IT, Fr0bolm LO. Expression of <strong>an</strong> inaccessible 1'1.7subtype cpitopc on meningococcal class 1 proteins. J Med Microbial 1993;38:23-8.26 Hopmnn CJP, D<strong>an</strong>kert J, v<strong>an</strong> Putten JPM. Variable expression of the class 1 protein of Neisseriameningitidis [abstract]. In: Proceedings of the 8th Intern<strong>at</strong>ional P<strong>at</strong>hogenic Neisseria Conference(Mexico). Mexico: 1992.2? Verhcul A Meningococcal LPS derived oligosaccharide-protein conjug<strong>at</strong>e vaccines. Immunochemical<strong>an</strong>d immunological aspects [thesis]. Utrecht, tb e Netherl<strong>an</strong>ds: Utrecht University, 1991.159 pp.28 Zollingcr WO, M<strong>an</strong>drclI RE. Outer membr<strong>an</strong>e protein <strong>an</strong>d lipopolysaccharide sero typing ofNeisseria mCllingitidis by inhibition of a solid phase radio-immunoassay. Infect Immun 1977; 18:424-434.29 Poolm<strong>an</strong> JT, Hopm<strong>an</strong> erp, Z<strong>an</strong>en He. Problems in the definition of meningococcal serolypes.FEMS Microbiol Lett 1982;13:339-348.30 M<strong>an</strong>drell RE, Kim CM, John CM, et aJ. Endogenous sialylalion of the lipooligosaccharides ofNeisseda meningitidis. J Bacterioll991;173:2823-32.31 Morrison DC. Bacterial endotoxins <strong>an</strong>d p<strong>at</strong>hogenesis. Rev Infect Dis 1983;5(suppl):S733-47.32 Br<strong>an</strong>dtzaeg P, Kierulf P, Gaustad P, et al. Plasma endotoxin as a predictor of multiple org<strong>an</strong> failure<strong>an</strong>d de<strong>at</strong>h in meningococc.,l disease. J Infect Dis 1989;159:195-204.33 Quagliarello V, Scheld WM. Bacterial meningitis: p<strong>at</strong>hogcncsis, p<strong>at</strong>hophysiology, <strong>an</strong>d progress. NEngl J Mcd 1992;327:864-72.34 Zollinger WD, M<strong>an</strong>dren RE. Type-specific <strong>an</strong>tigens of group A Neisseria mellillgitidis: lipopolysaccharides<strong>an</strong>d he<strong>at</strong> modifiable outer membr<strong>an</strong>e proteins. Infect Immun 1980;28:451-8.35 Crowe BA, Wall RA, Kusecek B, et al. Clonal <strong>an</strong>d variable properties of Neisseda meningitidisisol<strong>at</strong>ed from cases <strong>an</strong>d carriers during <strong>an</strong>d after <strong>an</strong> epidemic in the Gambia, West Africa. J InfectDi, 1989;159:686-700.36 Achtm<strong>an</strong> M, Kusecek B, Morelli G et aJ. A comparison of the variable <strong>an</strong>tigens expressed by cloneIV-I <strong>an</strong>d subgroup ill of Neisseda meningilidis serogroup A. J Infect Dis 1992;165:53-68.37 Jones DM, Borrow R, Fox Al, Gray S, Cartwright KA, Poolm<strong>an</strong> JT. The lipooligosaccharideimmunotype as a virulence detcrmin<strong>an</strong>t in Neisseria meningitidis. Microb P<strong>at</strong>hog 1992;13:219-224.38 lmmuniz.'tion Practices Advisory Committee (ACIP). Meningococcal vaccines. Recommend<strong>at</strong>ion ofthe Immuniz<strong>at</strong>ion Practices Advisory Committee. MMWR 1985~ 4 :255 - 9.39 <strong>An</strong>onymous. Preventing meningococcal infection. Drug Ther Bull 1990;28:34~6.40 B<strong>an</strong>d JD, Fraser DW, AjeJlo G, J-Iemophilus Influenzae Disease Study Group. Prevention ofHem ophilus ;'If!uenzae type b diseasc. JAMA 1984;251:2381-6.41 Munford RS, Taunay A de E, Souza de Morais J, Frascr DW, Feldm<strong>an</strong> RA. Sprcad ofmeningococcal infection within households. L<strong>an</strong>cet 1974;i:1275-8.42 Sp<strong>an</strong>jaa rd L, Bol P. Profylaxc bij bactcricle meningitis. Ned Tijdscbr Geneeskd 1990;134:575-7.43 <strong>An</strong>onymo us. Advies inzakc meningococcen immunis<strong>at</strong>i e. Leidschendam: Gewndhcidsraad, 1980.(Rapport no. 1980/13 v<strong>an</strong> de co mmissie "Meningococcen immunis<strong>at</strong>ic").44 Meningococcal Disease Surveill<strong>an</strong>ce Group. <strong>An</strong>alysis of cndcmic mcningococcal disease by serogroup<strong>an</strong>d evalu<strong>at</strong>ion of chemoprophylaxis. J Infect Dis 1976;134:201-4.45 Jacobson JA, Chester TJ, Fraser DW. <strong>An</strong> epidemic of disease due to serogroup B Neisseriamellillgitidis in Alabama: rcport of <strong>an</strong> investig<strong>at</strong>ion <strong>an</strong>d community-wide prophylaxis with asulfonamide. J Infect Dis 1977;136:104-8.46 Eickhoff TC. In-vitro <strong>an</strong>d in-vivo studies of resist<strong>an</strong>ce to rifampicin in meningococci. J Infect Dis1971 ;123:414-20.47 Schwartz B, Al-Tobaiqi A, Al-Ruwais A, er a1. Compar<strong>at</strong>ive cfficacy of ceftriaxonc <strong>an</strong>d rifampicin ineradic<strong>at</strong>ing pharyngeal carriage of group A Neisseria mellingitidis. L<strong>an</strong>cet 1988;i:I239-42.48 Dworzack 01.., S<strong>an</strong>ders CC, Horowitz EA, et af. Evalu<strong>at</strong>ion of single-dose ciprofloxacin in tbecradic.,tion of Neisseda menillgitidis [ram nasopharyngeal carriers. <strong>An</strong>timicrobial Agents <strong>an</strong>dChemotherapy 1988;32: 1740-1.49 Havens PL, Garl<strong>an</strong>d JS, Brook MM, Dewitz BA, Stremski ES, Troshynski TJ. Trends in mortalityin children hospitalized with meningococcal infections, 1957 to 1987. Pedi<strong>at</strong>r Infect Dis J 1989;8:8-11.96
SUMMARY